Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Cervical Cancer
- Colon Cancer
- Paediatric Cancers
- Adjuvant Therapy
- Sarcomas
- Prostate Cancer
- Immunotherapy
- Endometrial Cancer
Abstract
Citation: Clin Oncol. 2019;4(1):1626.DOI: 10.25107/2474-1663.1626
Acute Aortic Thrombosis Related to Adjuvant Capecitabine-Oxaliplatin in a Chinese Patient with Resected Adenocarcinoma of Sigmoid Colon
Henry CY Wong, Fiona MY Lim and Ashley CK Cheng
Department of Oncology, Princess Margaret Hospital, Hong Kong
*Correspondance to: Henry CY Wong
PDF Full Text Case Report | Open Access
Abstract:
Aortic thrombosis is a rare disease entity which has been reported to be related to malignancy and chemotherapeutic agents. Here we present the first case in literature about a colon cancer patient with well-controlled vascular risk factors who developed acute aortic thrombosis after the first cycle of adjuvant chemotherapy with capecitabine-oxaliplatin. Risk factors and causal relationship between systemic anti-cancer agents and this condition are reviewed and discussed.
Keywords:
Aortic thrombosis; Arterial thromboembolism; Capecitabine; Oxaliplatin
Cite the Article:
Wong HCY, Lim FMY, Cheng ACK. Acute Aortic Thrombosis Related to Adjuvant Capecitabine-Oxaliplatin in a Chinese Patient with Resected Adenocarcinoma of Sigmoid Colon. Clin Oncol. 2019; 4: 1626.